Corteva, Inc.

Company facts

Industry

Agricultural Production-Crops

Headquarters

Indianapolis, Indiana

Most recent report

8-K, filed Sep 25, 2026

Incorporated

Delaware

Filings on record

646 filings

On EDGAR

CIK 1755672

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 4 of 12 sections worth reading, with 2 positive, 11 notable, and 7 negative flags.

• Financial Statements (Item 1)

  Full financials: massive cash burn, debt surge, PFAS litigation, restructuring, pension contribution.
  Notable

  • 2026 Restructuring Actions: $78M severance in H1 2026, expected total ~$80M to align for planned business separation.
  • Bayer dispute settled: $610M payment (most paid), cross-license terminated, royalty obligations ended for Enlist E3 soybeans.
  • FTC and related antitrust lawsuits settled with total $121M litigation charge in H1 2026; accruals established.
  • NJ Statewide Settlement court approval indicated in June 2026; $875M payment over 25 years spread among parties.
  • Discretionary pension contribution of ~$1.5B approved; $1,061M contributed in June 2026, $399M in July.
  Negative

  • Crop Protection restructuring cost estimate increased to $750-815M from prior $650-700M, adding Asturias, Spain site cessation.
  • Short-term borrowings jumped to $3,193M from $894M; $2,422M in commercial paper and $600M drawn on 364-day facility.

• Management's Discussion (Item 2)

  MD&A packed with results, cash drop, debt surge, separation, and restructuring.
  Positive

  • Operating EBITDA in Q2 2026 grew 4% to $2,261M; H1 up 10% to $3,699M, driven by pricing, mix, and cost actions.
  • Seed segment operating EBITDA up 6% in Q2 and 11% in H1, with margin improvements over 200 basis points.
  Notable

  • Company announced plan to split into two public companies (Seed and Crop Protection) via tax-free spin-off.
  Negative

  • Q2 2026 net sales fell 1% to $6,379M, driven by 3% volume drop in North America and Brazil timing shifts.
  • Income from continuing ops after tax fell to $1,217M in Q2 2026 from $1,382M in Q2 2025, down 12%.
  • Crop Protection Q2 net sales down 4% to $1,847M, with price -4% and volume -2%; fungicides fell 23%.
  • H1 2026 operating cash flow was -$3,345M vs -$1,139M prior year, due to pension, litigation, and prepayment outflows.

• Legal Proceedings (Item 1)

  New dam failure incident and ongoing PFAS enforcement needs attention.
  Notable

  • Trial set for Sep 2026 in patent infringement case against Inari; May 2025 order reinstated estoppel defense.
  • Multiple municipal lawsuits in U.S. and Netherlands alleging PFOA/PFAS contamination from legacy EIDP businesses.
  • EPA issued CERCLA claims for PFAS cleanup costs from six sites; intent to retain designation confirmed in Sep 2025.
  Negative

  • New dam failure caused flooding and damage; no cost estimate given yet. Working with authorities.

• Exhibits (Item 6)

  Full EIDP financials: deep negative operating cash flow, pension spike, rising debt.
  Notable

  • Cash pooling arrangement changed from 'Master In-House Banking' to 'physical cash pooling'.
  • Corteva shares outstanding decreased to 667M from 670M in Q1 2026, suggesting buybacks.

What changed: Jun 2026 vs. Mar 2026

About 9% of CTVA's Jun 2026 10-Q is new information. 42 paragraphs were added, 195 changed, and 41 removed. Below are the most important lines SECSift identified.

• Item 1 89
• Item 2 68
• Item 6 8
• Item 4 4